The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist

Molecules. 2017 May 16;22(5):800. doi: 10.3390/molecules22050800.


5'-4-Alkyl/aryl-1H-1,2,3-triazole derivatives PILAB 1-12 were synthesized and a pharmacological screening of these derivatives was performed to identify a possible effect on the Central Nervous System (CNS) and to explore the associated mechanisms of action. The mice received a peritoneal injection (100 µmol/kg) of each of the 12 PILAB derivatives 10 min prior to the injection of pentobarbital and the mean hypnosis times were recorded. The mean hypnosis time increased for the mice treated with PILAB 8, which was prevented when mice were administered CTOP, a µ-opioid antagonist. Locomotor and motor activities were not affected by PILAB 8. The anxiolytic effect of PILAB 8 was evaluated next in an elevated-plus maze apparatus. PILAB 8 and midazolam increased a percentage of entries and spent time in the open arms of the apparatus compared with the control group. Conversely, a decrease in the percentages of entries and time spent in the closed arms were observed. Pretreatment with naloxone, a non-specific opioid antagonist, prior to administration of PILAB 8 exhibited a reverted anxiolytic effect. PILAB 8 exhibited antinociceptive activity in the hot plate test, and reduced reactivity to formalin in the neurogenic and the inflammatory phases. These data suggest that PILAB 8 can activate µ-opioid receptors to provoke antinociceptive and anti-inflammatory effects in mice.

Keywords: anti-inflammatory effect; antinociception; hypnosis; mice; novel µ-opioid agonist.

MeSH terms

  • Analgesics / therapeutic use
  • Animals
  • Anti-Anxiety Agents / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use
  • Anxiety / drug therapy
  • Anxiety / metabolism
  • Hypnotics and Sedatives / therapeutic use
  • Male
  • Mice
  • Morphine / therapeutic use
  • Naloxone / therapeutic use
  • Narcotic Antagonists / therapeutic use
  • Pain / drug therapy
  • Pain / metabolism
  • Pain Measurement
  • Receptors, Opioid / metabolism


  • Analgesics
  • Anti-Anxiety Agents
  • Anti-Inflammatory Agents
  • Hypnotics and Sedatives
  • Narcotic Antagonists
  • Receptors, Opioid
  • Naloxone
  • Morphine